An article covering the world’s first commercialization of a federated learning-based AI drug discovery platform—developed by Elix and LINC using AI models trained on data from 16 pharmaceutical companies—was featured in BioPharmaTrend and AI BRIEF on July 16, 2025, and in eCommerceNews Asia on July 18.

▼ BioPharmaTrend (July 16, 2025)
Japan’s Elix Launches AI Drug Discovery Platform Trained on Confidential Pharma Data via Federated Learning

▼ AI BRIEF – Daily AI BRIEF(July 16, 2025)
Elix and LINC Launch AI Drug Discovery Platform with Federated Learning

▼ eCommerceNews Asia(July 18, 2025)
Elix launches world’s first federated AI drug discovery platform